BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25024357)

  • 1. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.
    Mitra R; Edmonds MD; Sun J; Zhao M; Yu H; Eischen CM; Zhao Z
    RNA; 2014 Sep; 20(9):1356-68. PubMed ID: 25024357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.
    Mitra R; Zhao Z
    Int J Comput Biol Drug Des; 2014; 7(4):384-93. PubMed ID: 25539849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer.
    Li K; Li Z; Zhao N; Xu Y; Liu Y; Zhou Y; Shang D; Qiu F; Zhang R; Chang Z; Xu Y
    BMC Syst Biol; 2013 Nov; 7():122. PubMed ID: 24200043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
    Jin X; Guan Y; Zhang Z; Wang H
    BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.
    Najafi A; Tavallaei M; Hosseini SM
    Cancer Biomark; 2016; 16(1):31-45. PubMed ID: 26484609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Strategy for Identifying NSCLC MicroRNA Biomarkers and Their Mechanism Analysis Based on a Brand-New CeRNA-Hub-FFL Network.
    Zhang J; Nie R; Liu M; Zhang X
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncovering MicroRNA and Transcription Factor Mediated Regulatory Networks in Glioblastoma.
    Sun J; Gong X; Purow B; Zhao Z
    PLoS Comput Biol; 2012; 8(7):e1002488. PubMed ID: 22829753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.
    Liang CY; Li ZY; Gan TQ; Fang YY; Gan BL; Chen WJ; Dang YW; Shi K; Feng ZB; Chen G
    Respir Res; 2020 Feb; 21(1):60. PubMed ID: 32102656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.
    Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study.
    Mitra R; Lin CC; Eischen CM; Bandyopadhyay S; Zhao Z
    RNA; 2015 Jun; 21(6):1055-65. PubMed ID: 25852169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
    Recamonde-Mendoza M; Werhli AV; Biolo A
    Gene; 2019 May; 698():157-169. PubMed ID: 30844478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter- and intra-combinatorial regulation by transcription factors and microRNAs.
    Zhou Y; Ferguson J; Chang JT; Kluger Y
    BMC Genomics; 2007 Oct; 8():396. PubMed ID: 17971223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors.
    Qin G; Mallik S; Mitra R; Li A; Jia P; Eischen CM; Zhao Z
    Sci Rep; 2020 Jan; 10(1):852. PubMed ID: 31965022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
    Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
    BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics Analysis Predicts hsa_circ_0026337/miR-197-3p as a Potential Oncogenic ceRNA Network for Non-Small Cell Lung Cancers.
    Zhang Q; Kang L; Li X; Li Z; Wen S; Fu X
    Anticancer Agents Med Chem; 2022; 22(5):874-886. PubMed ID: 34254931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.